Structure |
Chemical Name |
CAS |
MF |
|
Leuprorelin EP Impurity F |
1872435-00-1 |
C59H84N16O12 |
|
Dapagliflozin Impurity 10 |
461432-27-9 |
C21H25ClO7 |
|
Levetiracetam impurity 2 |
1341459-52-6 |
C8H17N3O2 |
|
(S)-5-chloro-N-(3-(5-chlorothiophene-2-carboxamido)-2- hydroxypropyl)-N-(4-(3-oxomorpholino)phenyl)thiophene-2- carboxamide |
2204368-63-6 |
C23H21Cl2N3O5S2 |
|
Ezetimibe Impurity 38 |
1701462-59-0 |
C45H58F2N2O5Si2 |
|
Indapamide Impurity F |
62574-66-7 |
C7H3Cl3O3S |
|
Moxifloxacin Impurity 38 |
1262758-66-6 |
C21H24FN3O5 |
|
Nimodipine Impurity 3 |
101072-61-1 |
C11H9NO5 |
|
Pitavastatin Impurity 40 |
|
|
|
Ritonavir EP Impurity R |
|
|
|
Ticagrelor Impurity 68 |
1643378-46-4 |
C23H29FN6O4S |
|
Tofacitinib Impurity 70 |
|
|
|
Amifostine Impurity 6 |
|
|
|
Aztreonam Impurity 6 |
|
|
|
Clarithromycin Impurity EP G |
107216-09-1 |
C39H72N2O13 |
|
Dapagliflozin Impurity 32 |
|
|
|
Doxofylline Impurity 7 |
43135-57-5 |
C13H20N4O4 |
|
Erlotinib Impurity 55 |
|
|
|
Etoposide Impurity 1 |
|
|
|
Etoposide Impurity 6 |
|
|
|
Olaparib Impurity 34 |
|
|
|
Oseltamivir Impurity 15 |
2254819-34-4 |
C22H36N2O4 |
|
Oseltamivir Impurity 27 |
|
|
|
Pitavastatin Impurity 20 |
|
|
|
Rocuronium Bromide Impurity 20 |
|
|
|
Rocuronium Bromide Impurity 9 |
|
|
|
Verapamil Impurity N |
2086274-75-9 |
C33H47N3O4 |
|
Ergoline-8-carboxylic acid, 2-bromo-9,10-didehydro-6-methyl-, (8β)- |
478-83-1 |
C16H15BrN2O2 |
|
Dextrorotation lansoprazole Impurity J |
|
|
|
Dextrorotation lansoprazole-N-oxide |
|
|
|
lansoprazole Impurity 23 |
|
|
|
lansoprazole Impurity 29 |
|
|
|
Loratadine Impurity L |
|
C22H23ClN2O2 |
|
meta-dyhydroxy Sugammadex sodium Impurity 1 |
|
|
|
Olanzapine impurity R |
|
C17H20N4S |
|
Palbociclib Impurity 33 |
|
|
|
Pramipexole Related Impurity 1 |
|
|
|
Ropivacaine Impurity 37 |
|
|
|
Ropivacaine Impurity 42 |
|
|
|
Sugammadex sodium Org197339-1 Impurity |
|
|
|
Fludarabine EP impurity G |
548774-56-7 |
C10H12ClFN5O6P |
|
Sitagliptin Impurity 12 |
1803026-54-1 |
C16H12F6N4O |
|
Butyphthalide impurity 44 |
952413-01-3 |
C13H18O3 |
|
Cabozantinib impurity 24 |
|
|
|
Celecoxib Impurity 18 |
2271123-54-5 |
C11H9F3O2 |
|
Dapoxetine impurity 22 |
|
|
|
Febuxostat Impurity 85 |
|
|
|
Fosaprepitant Impurity NLS |
|
|
|
Irinotecan Impurity 17 HCl |
1332610-75-9 |
C19H14N2O4 |
|
LCZ696(valsartan + sacubitril) impurity 31 |
|
|
|
Lenvatinib Impurity 24 |
|
|
|
Lenvatinib Impurity 30 |
|
|
|
Regorafenib Impurity 22 |
|
|
|
Regorafenib Impurity 28 |
|
|
|
(E)-methyl 3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
|
|
2-フルオロ-4-アセチル-1,1'-ビフェニル |
42771-79-9 |
C14H11FO |
|
4-ヒドロキシベンゼン-1,3-ジメタノール |
2937-60-2 |
C8H10O3 |
|
Oseltamivir Impurity 107 |
|
|
|
Oseltamivir Impurity 66 |
|
|
|
Dapagliflozin Impurity 46 |
|
|
|
Brexpiprazole Impurity ABCDEFGHJKL |
|
|
|
4,4'-(2-ピリジニルメチレン)ビスフェノール |
603-41-8 |
C18H15NO2 |
|
Tazobactam Impurity DBT |
|
|
|
3β-[4-O-[4-O-(2,6-ジデオキシ-β-D-ribo-ヘキソピラノシル)-2,6-ジデオキシ-β-D-ribo-ヘキソピラノシル]-2,6-ジデオキシ-β-D-ribo-ヘキソピラノシルオキシ]-12β,14,16β-トリヒドロキシ-5β-カルダ-20(22)-エノリド |
52589-12-5 |
C41H64O15 |
|
Thiophene, 2-(2-fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]- |
2436275-33-9 |
C18H14FIS |
|
Revefenacin Impurity 2 |
1158699-78-5 |
C14H17NO4 |
|
(R)-2-(4-Methoxyphenyl)-1-methylethanamine |
58993-79-6 |
C10H15NO |
|
N-[5-[(1RS)-2-[benzyl[(1RS)-2-(4-methoxyphenyl)- 1-methylethyl]amino]-1-hydroxyethyl]-2- hydroxyphenyl]formamide |
2514947-17-0 |
C26H30N2O4 |
|
Peramivir dehydrated deacetylated impurity |
|
|
|
Cilastatin Impurity H |
|
|
|
(trans, trans)-3,3'-(1,4,7,10-tetraazacyclododecane-1,7-diyl)bis(butane-1,2,4-triol) |
|
|
|
Azelastine Impurity K |
|
|
|
(4R,6R)-6-(2-((1S,2S)-2,6-dimethyl-1,2,3,4-tetrahydronaphthalen-1- |
|
|
|
Carbazochrome Sodium Sulfonate Impurity 1 |
|
|
|
Rosuvastatin Impurity 147 |
|
|
|
Sitafloxacin Impurity ZZ-C-01 |
|
|
|
Tofacitinib Impurity 85 |
2268720-86-9 |
C20H24ClN5 |
|
Tofacitinib Impurity 90 |
|
|
|
Nintedanib Impurity M |
|
|
|
Citalopram Impurity 14 |
1470362-85-6 |
C20H23FN2O2 |
|
(S)-methyl 2-(2,3-bis(hydroxymethyl)-6,7-dihydrothieno[3,2-c] pyridin-5(4H)-yl)-2-(2-chlorophenyl)acetate |
1346231-36-4 |
C18H20ClNO4S |
|
Capecitabine impurity 6 |
|
|
|
Vilanterol Impurity 25 |
1027529-99-2 |
C13H15NO4 |
|
Sugammadex sodium Org139131-1 Impurity |
|
|
|
Dolutegravir Impurity 16 |
1357289-37-2 |
C20H19F2N3O5 |
|
Tofacitinib Impurity 98 |
|
|
|
Cabozantinib impurity 30 |
|
|
|
Cabozantinib impurity 35 |
1905820-17-8 |
|
|
Carvedilol Impurity DBA |
3258-70-6 |
C18H23NO4 |
|
Pregabalin Impurity 9 |
44855-96-1 |
C5H7NO3 |
|
Butyphthalide impurity 50 |
|
|
|
Canagliflozin Impurity 40 |
|
|
|
Pralatrexate Impurity 4 |
1445586-42-4 |
C18H15N5O3 |
|
Pralatrexate Impurity 9 |
1548618-61-6 |
C23H22N6O6 |
|
N-(3-chloro-4-fluorophenyl)-7 -methoxy-6-(3-morpholinopropoxy)-N-(3-morpholinopropyl)quinazolin-4-amine |
1502829-45-9 |
C29H37ClFN5O4 |
|
5-(hydroxymethyl)-1,2-dihydro-1,2,4-triazol-3-one |
24021-90-7 |
C3H5N3O2 |
|
( 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butylester ) |
475084-96-9 |
C29H37N3O3 |
|
4-(1,4,8,11-テトラアザシクロテトラデカン-1-イルメチル)ベンゼンメタノール |
176252-20-3 |
C18H32N4O |
|
Alvimopan Impurity 3 |
|
|
|
Nicergoline Impurity G |
|
|